Disulfide isomerase ERp57 improves the stability and immunogenicity of H3N2 influenza virus hemagglutinin

[1]  Yun Zhang,et al.  Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus , 2019, Viruses.

[2]  Yun Zhang,et al.  Biological characteristics and immunological properties in Muscovy ducks of H5N6 virus-like particles composed of HA-TM/HA-TMH3 and M1 , 2018, Avian pathology : journal of the W.V.P.A.

[3]  Yun Zhang,et al.  H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice , 2018, Vaccine.

[4]  S. Wells,et al.  ‘Something in the way she moves’: The functional significance of flexibility in the multiple roles of protein disulfide isomerase (PDI) , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[5]  Jialing Wu,et al.  Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice. , 2017, Virus research.

[6]  Jialing Wu,et al.  A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross‐reactive antibodies and improved interclade protection in mice , 2017, Antiviral research.

[7]  F. Krammer,et al.  Universal influenza virus vaccines and therapeutic antibodies. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  Su-Jin Park,et al.  Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy , 2017, Journal of Virology.

[9]  J. Treanor.  Prospects for Broadly Protective Influenza Vaccines. , 2015, American journal of preventive medicine.

[10]  Adrian Apetri,et al.  A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen , 2015, Science.

[11]  Yongchang Cao,et al.  Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice. , 2015, Vaccine.

[12]  I. Margine,et al.  Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. , 2015, Vaccine.

[13]  P. Palese,et al.  Advances in the development of influenza virus vaccines , 2015, Nature Reviews Drug Discovery.

[14]  R. Webster,et al.  Continuing challenges in influenza , 2014, Annals of the New York Academy of Sciences.

[15]  Yongchang Cao,et al.  Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice , 2014, Vaccine.

[16]  Yongchang Cao,et al.  Evidences for the existence of intermolecular disulfide-bonded oligomers in the H3 hemagglutinins expressed in insect cells , 2014, Virus Genes.

[17]  Yongchang Cao,et al.  Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics , 2014, Virus Genes.

[18]  Florian Krammer,et al.  Influenza virus hemagglutinin stalk-based antibodies and vaccines. , 2013, Current opinion in virology.

[19]  K. Mineev,et al.  Structural investigation of influenza virus hemagglutinin membrane-anchoring peptide. , 2013, Protein engineering, design & selection : PEDS.

[20]  Yongchang Cao,et al.  Mutations of two transmembrane cysteines of hemagglutinin (HA) from influenza A H3N2 virus affect HA thermal stability and fusion activity , 2013, Virus Genes.

[21]  J. Whittle,et al.  Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies , 2013, Nature.

[22]  P. Palese,et al.  Toward a universal influenza virus vaccine: prospects and challenges. , 2013, Annual review of medicine.

[23]  António M. Baptista,et al.  Structural Determinants for the Membrane Insertion of the Transmembrane Peptide of Hemagglutinin from Influenza Virus , 2012, J. Chem. Inf. Model..

[24]  I. Braakman,et al.  Protein folding and modification in the mammalian endoplasmic reticulum. , 2011, Annual review of biochemistry.

[25]  J. Yewdell,et al.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection , 2011, The Journal of experimental medicine.

[26]  R. Compans,et al.  Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin , 2010, PloS one.

[27]  Steven J. Gamblin,et al.  Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins , 2010, The Journal of Biological Chemistry.

[28]  Feras Hatahet,et al.  Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. , 2009, Antioxidants & redox signaling.

[29]  Nicole M. Bouvier,et al.  The biology of influenza viruses. , 2008, Vaccine.

[30]  Wei Shi,et al.  Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus , 2008, Journal of Virology.

[31]  D. Chang,et al.  Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. , 2008 .

[32]  Amy S. Lee,et al.  ER chaperones in mammalian development and human diseases , 2007, FEBS letters.

[33]  Masa Cemazar,et al.  Protein disulfide isomerase: the structure of oxidative folding. , 2006, Trends in biochemical sciences.

[34]  M. Molinari,et al.  Consequences of ERp57 Deletion on Oxidative Folding of Obligate and Facultative Clients of the Calnexin Cycle* , 2006, Journal of Biological Chemistry.

[35]  K. Vandenbroeck,et al.  Multi-chaperone complexes regulate the folding of interferon-γ in the endoplasmic reticulum , 2006 .

[36]  M. Cox,et al.  Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine , 2005, Vaccine.

[37]  R. Compans,et al.  Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens , 2004, Journal of Virology.

[38]  S. Tatulian,et al.  Secondary structure, orientation, oligomerization, and lipid interactions of the transmembrane domain of influenza hemagglutinin. , 2000, Biochemistry.

[39]  R. Doms,et al.  Quaternary structure of influenza virus hemagglutinin after acid treatment , 1986, Journal of virology.

[40]  Ronghan Liu,et al.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases , 2018, Pharmacology & therapeutics.

[41]  K. Subbarao,et al.  Influenza vaccines: challenges and solutions. , 2015, Cell host & microbe.

[42]  K. Vandenbroeck,et al.  Multi-chaperone complexes regulate the folding of interferon-gamma in the endoplasmic reticulum. , 2006, Cytokine.

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..